"The CSL Student Conference was started in 2006 and, through the years, has been organized by graduate students in CSL. The first edition primarily focused on the areas of Communication, Control, and ...

Jarden analyst Steven Wheen maintained a Buy rating on CSL (CMXHF – Research Report) on February 3 and set a price target of A$329.62. The company’s shares closed last Monday at $161.37.

Learn More If you have been thinking about buying CSL Ltd (ASX: CSL) shares, then read on. That's because Goldman Sachs has just named another reason to buy the biotechnology giant's shares.

A new approach to treating inflammatory diseases through personalized probiotic therapies – also known as precision medicine – has been proposed by researchers at the University of Surrey. The ...

Goldman Sachs analyst Davinthra Thillainathan maintained a Buy rating on CSL (CMXHF – Research Report) today and set a price target of A$325.40. The company’s shares closed yesterday at $170.75.

#1. CSL Key milestones: 2007: CSL hit $100 before its 3-for-1 split. 2015: CSL hit $100 (again) 2018: Cracked $200. 2020: First surpassed $300. Note: CSL would technically be above $500 were it not ...